Delivery Order SPE2DB20D2014-SPE2DB25FC49W
- Not listed
- The Defense Logistics Agency awarded a $17,181.12 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram unit, valued at $1,845.53 under a firm fixed-price contract structure. This is a non-set-aside competitive award with an ultimate completion date of October 29, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,139.48 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price, non-set-aside contract with a completion date of September 16, 2025, and performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.56 to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is set to be completed by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a $26,873.19 delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Opzelura 1.5% cream in 60-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 16, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units, with a ceiling value of $5,890.17 and an ultimate completion date of November 4, 2025. This non-set-aside, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 billion and extends through December...
- This delivery order, awarded on July 28, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Opzelura 1.5% Cream in 60-gram units with a ceiling value of $1,310.45. The award represents a firm fixed-price delivery order under a non-competitive, non-set-aside procurement, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $23,120.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in 60-gram quantities, with a completion date of July 31, 2025. This non-set-aside award was issued on July 30, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC49WDelivery Order
The Defense Logistics Agency awarded a $6,822.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside competitive award with an ultimate completion date of July 21, 2025, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds a significant position within the federal medical supply chain. The company's DLA contract vehicle enables it to supply a broad range of pharmaceutical products and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This particular delivery order for Opzelura cream represents a routine pharmaceutical fulfillment under the larger prime vendor agreement, consistent with the company's extensive portfolio of competitively awarded federal contracts spanning diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/18/25 |